Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 1218
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, and dairy flavoring products; active pharmaceutical ingredients, such as dry extract powders, viscous extracts, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Ca-CMC; health subsidiary...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, tr
Data is available to registered users only
Buy
Sell